Lifemd Offers Novo Nordisk's Ozempic For $499 A Month To Eligible Patients

2025-09-30 10:15:28

(MENAFN- AsiaNet News)

LifeMD Inc. (LFMD) announced on Tuesday that it has partnered with Novo Nordisk AS (NVO) to offer Ozempic through an integration with NovoCare Pharmacy to eligible patients.

According to the company's announcement, eligible self-pay and uninsured patients, as well as insured patients whose plans do not cover GLP-1 therapies, now have direct access to all FDA-approved dose strengths of Ozempic within LifeMD's end-to-end virtual care platform for $499 a month.

Get updates to this story developing <directly on Stocktwits<.

For updates and corrections, email newsroom[at]stocktwits[dot]com.

MENAFN30092025007385015968ID1110131183

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.